Phase I first-in-human study of CUDC-101, a multitargeted inhibitor of HDACs, EGFR, and HER2 in patients with advanced solid tumors (Q42704536)
Jump to navigation
Jump to search
scientific article published on 8 August 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I first-in-human study of CUDC-101, a multitargeted inhibitor of HDACs, EGFR, and HER2 in patients with advanced solid tumors |
scientific article published on 8 August 2014 |
Statements
1 reference
Phase I first-in-human study of CUDC-101, a multitargeted inhibitor of HDACs, EGFR, and HER2 in patients with advanced solid tumors (English)
1 reference
Toshio Shimizu
1 reference
Patricia M LoRusso
1 reference
Kyri P Papadopoulos
1 reference
Amita Patnaik
1 reference
Muralidhar Beeram
1 reference
Lon S Smith
1 reference
Drew W Rasco
1 reference
Theresa A Mays
1 reference
Glenda Chambers
1 reference
Anna Ma
1 reference
Jing Wang
1 reference
Robert Laliberte
1 reference
Maurizio Voi
1 reference
Anthony W Tolcher
1 reference
8 August 2014
1 reference
1 reference
Identifiers
1 reference